Effects of prolonged use of meloxicam in healthy horses: clinical, laboratory, gastroscopic, and electrocardiographic findings

Authors

DOI:

https://doi.org/10.5433/1679-0359.2024v45n4p1047

Keywords:

Adverse effect, Anti-inflammatory, electrocardiogram, Gastroscopy, Equine.

Abstract

Non-steroidal anti-inflammatory drugs are extensively used in veterinary practice. COX-2 inhibitors are considered to be safer than non-selective inhibitors; however, there are few studies address of their long-term use in equine species. The goal of this study was to identify the possible adverse effects of meloxicam (a preferential COX-2 inhibitor) in healthy horses, administered at a dose of 0.6 mg/kg, orally, once a day, for 28 days. A paired test was performed with seven animals, and the clinical, hematological, biochemical, and gastroscopic parameters, as well as bleeding time, were evaluated in five timepoints and an electrocardiogram at three timepoints. No relevant adverse effects were observed in terms of the parameters evaluated. Significant differences were found in heart rate, AST and P wave duration, segmented neutrophils (%), and the levels of erythrocytes, hemoglobin, hematocrit, and MCH, compared with these parameters at T0; however, no animal manifested clinical alterations. Gastroscopy revealed discrete lesions (Grade 1) in the squamous gastric mucosa on day 14 of treatment in all animals; however, at the end of the study (day 28) these lesions had regressed to grade 0 in three of the horses and remained at grade 1 in the other four animals. Based on these results, we conclude that the use of meloxicam at a daily dose of 0.6 mg/kg, orally, for 28 consecutive days, did not cause relevant adverse effects in healthy horses.

Author Biographies

Dinamérico de Alencar Santos Júnior, Universidade Federal do Oeste da Bahia

Prof. Dr., Veterinary Medicine Course, Centro Multidisciplinar de Barra, Universidade Federal do Oeste da Bahia, UFOB, Barra, BA, Brazil.

Caio Victor Damasceno Carvalho, Universidade Federal da Bahia

Prof. Dr., Veterinary Medicine Course, Universidade Federal da Bahia, Salvador, BA, Brazil.

Maynara Kalya Ferreira Lima, Universidade Federal de Alagoas

Undergraduate Student of Veterinary Medicine, Universidade Federal de Alagoas, UFAL, Viçosa, AL, Brazil.

Eldinê Gomes de Miranda Neto, Universidade Federal de Campina Grande

Prof. Dr., Veterinary Medicine Course, Universidade Federal de Campina Grande, UFCG, Patos, PB, Brazil.

Pierre Barnabé Escodro, Universidade Federal de Alagoas

Prof. Dr., Veterinary Medicine Course, UFAL, Viçosa, AL, Brazil.

References

Alves, J. E. O., Vieira, E. M. P., Sartori, F., & Catelli, M. F. (2016). Aspectos clínicos e experimentais da dor em equinos: revisão de literatura (Clinical and experimental aspects of pain in equines: literature review). Science and Animal Health, 4(2), 131-147. doi: 10.15210/sah.v4i2.6472

Andrews, F. M., Buchanan, B. R., Smith, S. H., Elliot, S. B., & Saxton, A. M. (2006). In vitro effects of hydrochloric acid and various concentrations of acetic, propionic, butyric, or valeric acids on bioelectric properties of equine gastric squamous mucosa. American Journal of Veterinary Research, 67(11), 1873-1882. doi: 10.2460/ajvr.67.11.1873

Brideau, C., Staden, C. V., & Chan, C. C. (2001). In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs and cats. American Journal of Veterinary Research, 62(11), 1755-1760. doi: 10.2460/ajvr.2001.62.1755

Fernandes, W. R., Larsson, M. H. M. A., Alves, A. L. G., Fantoni, D. T., & Belli, C. B. (2004). Características eletrocardiográficas em equinos clinicamente normais da raça Puro Sangue Inglês (Electrocardiographic parameters in clinically healthy thoroughbred horses). Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 56(2), 143-149. doi: 10.1590/S0102-09352004000200002

Hewetson, M., Sykes, B. W., Hallowell, G. D., & Tulamo, R. M. (2017). Diagnostic accuracy of blood sucrose as a screening test for equine gastric ulcer syndrome (EGUS) in adult horses. Acta Veterinaria Scandinavica, 59(15). doi: 10.1186/s13028-017-0284-1

Kaneko, J., Harvey, J., & Bruss, M. (2008). Clinical biochemistry of domestic animals (6nd ed.). Academic Pres.

Kerr, M. G. (2003). Exames laboratoriais em medicina veterinária. São Paulo.

Kivett, L., Taintor, J., & Wright, J. (2014). Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses. Journal of Veterinary Pharmacology and Therapeutics, 37(4), 413-416. doi: 10.1111/jvp.12097

Knottenbelt, D. C., & Malalana, F. (2015). Saunders equine formulary (2nd ed.). Elsevier.

Lorenzo‐Figueras, M., & Merritt, A. (2002). Effects of exercise on gastric volume and pH in the proximal portion of the stomach of horses. American Journal of Veterinary Research, 63(11), 1481-1487. doi: 10.2460/ajvr.2002.63.1481

Luna, S. P. L., Basílio, A. C., Steagall, P. V. M., Machado, L. P., Moutinho, F. Q., Takahira, R. K., & Brandão, C. V. S. (2007). Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. American Journal of Veterinary Research, 68(3), 258-264. doi: 10.2460/ajvr.68.3.258

Malfertheiner, P., Chan, F. F. K. L., McColl, K. E. L., & Leung, W. (2009). Peptic‐ulcer disease. Lancet, 374(9699), 1449-1461. doi: 10.1016/S0140-6736(09)60938-7

McConnico, R. S., Morgan, T. W., Williams, C. C., Hubert, J. D., & Moore, R. M. (2008). Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses. American Journal of Veterinary Research, 69(11), 1496-1505. doi: 10.2460/ajvr.69.11.1496

Mendes, R. T., Stanczyk, C. P., Sordi, R., Otuki, M. F., Santos, F. A., & Fernandes, D. (2012). Selective inhibition of cyclooxygenase-2: risks and benefits. Revista Brasileira de Reumatologia, 52(5), 767-782.

Mendoza, F. J., Serrano-Rodriguez, J. M. S., & Perez-Ecija, A. (2019). Pharmacokinetics of meloxicam after oral administration of a granule formulation to healthy horses. Journal of Veterinary Internal Medicine, 33(2), 961-967. doi: 10.1111/jvim.15433

Menozzi, A., Pozzoli, C., Poli, E., Dacasto, M., Giantin, M., Lopparelli, R. M., Passeri, B., Zullian, C., Gobbetti, T., & Bertini, S. (2009). Effects of nonselective and selective cyclooxygenase inhibitors on small intestinal motility in the horse. Research in Veterinary Science, 86(1), 129-135. doi: 10.1016/j.rvsc.2008.04.006

Merritt, A. M., Sanchez, L. C., Burrow, J. A., & Ludzia, C. S. (2003). Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses. Equine Veterinary Journal, 35(7), 691-695. doi: 10.2746/042516403775696339

Nadeau, J. A., Andrews, F. M., Patton, C. S., Argenzio, R. A., Mathew, A. G., & Saxton, A. M. (2003). Effects of hydrochloric, valeric, and other volatile fatty acids on pathogenesis of ulcers in the nonglandular portion of the stomach of horses. American Journal of Veterinary Research, 64(4), 413-417. doi: 10.2460/ajvr.2003.64.413

Noble, G., Edwards, S., Lievaart, L., Pippia, J., Boston, R., & Raidal, S. L. (2012). Pharmacokinetics and safety of single and multiple oral doses of meloxicam in adult horses. Journal of Veterinary Internal Medicine, 26(5), 1192-1201. doi: 10.1111/j.1939-1676.2012.00976.x

Pedersen, S. K., Cribb, A. E., Ler, E. K., Francês, D., & Banse, E. L. E. (2018). Phenylbutazone induces equine glandular gastric disease without decreasing prostaglandin E2 concentrations. Journal of Veterinary Pharmacology and Therapeutics, 41(2), 239-245. doi: 10.1111/jvp.12464

Santos, D. A., Jr., Oliveira, E. F., Fº., Miranda, E. G., Neto, & Escodro, P. B. (2020). Efeitos adversos do uso prolongado de anti-inflamatórios não esteroidais inibidores da COX-2 em equinos: revisão (Adverse effects of prolonged use non-steroidal anti-inflammatory drugs that inhibit COX-2 in horses: review). Research, Society and Development, 9(9), e609997747. doi: 10.33448/rsd-v9i9.7747

Santos, R. S. T., Pereira, M. A. A., Garcia, S. G., Fº., Spagnolo, J. D., Ambrosio, A. M., & Fantoni, D. T. (2018). Correlação entre o uso de anti-inflamatórios não esteroidais e efeitos adversos em equinos: revisão bibliográfica (Correlation between the use of nonsteroidal antiinflammatory use causing side effects in equine: review article). Revista Brasileira de Medicina Equina, 13(78), 14-22.

Savage, V. L., Marr, C. M., Bailey, M., & Smith, S. (2019). Prevalence of acute kidney injury in a population of hospitalized horses. Journal of Veterinary Internal Medicine, 33(5), 2294-2301. doi: 10.1111/jvim.15569

Schott II, H. C., & Esser, M. M. (2020). The sick adult horse: renal clinical pathologic testing and urinalysis. Veterinary Clinics of North America: Equine Practice, 36(1), 121-134. doi: 10.1016/j.cveq.2019.12.003

Shi, S., & Klotz, U. (2008). Clinical use and pharmacological properties of selective COX-2 inhibitors. Europena Journal of Clinical Pharmacology, 64(3), 233-252. doi: 10.1007/s00228-007-0400-7

Speirs, V. C. (1999). Exame clínico de equinos. Editora Artes Médica Sul.

Sykes, B. W., Hewetson, M., Hepburn, R. J., Luthersson, N., & Tamzali, Y. (2015). European college of equine internal medicine consensus statement - equine gastric ulcer syndrome in adult horses. Journal of Veterinary Internal Medicine, 29(5), 1288-1299. doi: 10.1111/jvim.13578

Tesena, P., Yingchutrakul, Y., Roytrakul, S., Wongtawan, T., & Angkanaporn, K. (2019). Serum protein expression in Equine Glandular Gastric Disease (EGGD) induced by phenylbutazone. Journal of Veterinary Medical Science, 81(3), 418-424. doi: 10.1292/jvms.18-0679

Vaithianathan, R., Hockey, P. M., Moore, T. J., & Bates, D. W. (2009). Iatrogenic effects of COX-2 inhibitors in the US population: findings from the medical expenditure panel survey. Drug Safety, 32(4), 335-343. doi: 10.2165/00002018-200932040-00007

Van Galen, G., Saegerman, C., Laursen, S. H., Jacobsen, S., Munk, M. A., Sjöström, H., Lindmark, S. H., & Verwilghen, D. (2021). Colonic health in hospitalized horses treated with non-steroidal anti-inflammatory drugs - a preliminary study. Journal of Equine Veterinary Scienses, 101, 103451. doi: 10.1016/j.jevs.2021.103451

Veronezi, R. C., Nunes, P. G., Cassol, D. M. S., Toma, S. B., Thomassian, A., & Alves, A. L. G. (2006). Avaliação da eficácia e segurança do meloxicam administrado por via oral em equinos (Evaluation efficacy and safety of the orally administered meloxicam in horses). Revista Brasileira de Medicina Equina, 1(4), 11-17.

Vivancos, M., Barker, J., Engbers, S., Fischer, C., Frederick, J., Friedt, H., Rybicka, J. M., Stastny, T., Banse, H., & Cribb, A. E. (2015). Pharmacokinetics and bioequivalence of 2 meloxicam oral dosage formulations in healthy adult horses. Canadian Veterinary Journal, 56(7), 730-736.

Ziegler, A., Fogle, C., & Blikslager, A. (2017). Update on the use of cyclooxygenase-2–selective nonsteroidal anti-inflammatory drugs in horses. Review article. Journal of the American Veterinary Medical Association, 250(11), 1271-1274. doi: 10.2460/javma.250.11.1271

Downloads

Published

2024-07-01

How to Cite

Santos Júnior, D. de A., Carvalho, C. V. D., Lima, M. K. F., Miranda Neto, E. G. de, & Escodro, P. B. (2024). Effects of prolonged use of meloxicam in healthy horses: clinical, laboratory, gastroscopic, and electrocardiographic findings. Semina: Ciências Agrárias, 45(4), 1047–1064. https://doi.org/10.5433/1679-0359.2024v45n4p1047

Issue

Section

Articles

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.